Strides Arcolab has reported results for third quarter ended December 31, 2014.
The company has registered a fall of 97.24% in its net profit after tax at Rs 97.40 crore for the quarter under review as compared to Rs 3525.24 crore for the same quarter in the previous year. However, total income of the company has increased 7.08% at Rs 288.21 crore for Q3FY15 as compared Rs 269.16 crore for the corresponding quarter previous year.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
